# EDGAR Filing Document

**Accession Number:** 0000095029
**File Stem:** 0001174947-26-000554
**Filing Date:** 2026-5
**Character Count:** 97425
**Document Hash:** 41528539ea83bdfb8a67298635f790e2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001174947-26-000554.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001174947-26-000554

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 62

**CONFORMED PERIOD OF REPORT**: 20260328

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STURM RUGER & CO INC
- **CENTRAL INDEX KEY:** 0000095029
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 060633559
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10435
- **FILM NUMBER:** 26948294

**BUSINESS ADDRESS:**
- **STREET 1:** 1 LACEY PLACE
- **CITY:** SOUTHPORT
- **STATE:** CT
- **ZIP:** 06490
- **BUSINESS PHONE:** 2032597843

**MAIL ADDRESS:**
- **STREET 1:** 1 LACEY PLACE
- **CITY:** SOUTHPORT
- **STATE:** CT
- **ZIP:** 06490

?xml version='1.0' encoding='ASCII'? rgr-20260328

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended <u>March 28, 2026</u>

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from_______________ to _______________

Commission file number <u>1-10435</u>

---

| |
|:---|
| &nbsp;&nbsp;STURM, RUGER & COMPANY, INC. |
| &nbsp;&nbsp;(Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;Delaware | &nbsp;&nbsp;06-0633559 |
| &nbsp;&nbsp;(State or other jurisdiction of | &nbsp;&nbsp;(I.R.S. employer |
| &nbsp;&nbsp;incorporation or organization) | &nbsp;&nbsp;identification no.) |
| &nbsp;&nbsp;One Lacey Place, Southport, Connecticut | &nbsp;&nbsp;06890 |
| &nbsp;&nbsp;(Address of principal executive offices) | &nbsp;&nbsp;(Zip code) |

---

<u>(203) 259-7843</u>

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Title of each class | &nbsp;&nbsp;Trading Symbol(s) | &nbsp;&nbsp;Name of each exchange on which registered |
| &nbsp;&nbsp;Common Stock, $1 par value | &nbsp;&nbsp;RGR | &nbsp;&nbsp;New York Stock Exchange |
| &nbsp;&nbsp;Common Stock Purchase Rights | &nbsp;&nbsp;N/A | &nbsp;&nbsp;New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the issuer's common stock as of April 15, 2026: 15,944,253

INDEX

STURM, RUGER & COMPANY, INC.

---

| | | |
|:---|:---|:---|
| <u>PART I.</u> | <u>[FINANCIAL INFORMATION](#a_001)</u> |  |
| Item 1. | [Financial Statements (Unaudited)](#a_002) |  |
|  | [Condensed consolidated balance sheets – March 28, 2026 and December 31, 2025](#a_003) | 3 |
|  | [Condensed consolidated statements of income and comprehensive income – Three months ended March 28, 2026 and March 29, 2025](#a_004) | 5 |
|  | [Condensed consolidated statements of stockholders' equity – Three months ended March 28, 2026 and March 29, 2025](#a_005) | 6 |
|  | [Condensed consolidated statements of cash flows – Three months ended March 28, 2026 and March 29, 2025](#a_006) | 7 |
|  | [Notes to condensed consolidated financial statements](#a_007) | 8 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_008) | 22 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_009) | 31 |
| Item 4. | [Controls and Procedures](#a_010) | 31 |
| <u>PART II.</u> | <u>[OTHER INFORMATION](#a_011)</u> |  |
| Item 1. | [Legal Proceedings](#a_012) | 32 |
| Item 1A. | [Risk Factors](#a_013) | 32 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#a_014) | 32 |
| Item 3. | [Defaults Upon Senior Securities](#a_015) | 32 |
| Item 4. | [Mine Safety Disclosures](#a_016) | 32 |
| Item 5. | [Other Information](#a_017) | 33 |
| Item 6. | [Exhibits](#a_018) | 34 |
| <u>[SIGNATURES](#a_019)</u> | <u>[SIGNATURES](#a_019)</u> | 35 |

---

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

STURM, RUGER & COMPANY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

*(Dollars in thousands)*

---

| | | |
|:---|:---|:---|
| | March 28, 2026 | December 31, 2025 |
|  | | (Note) |
| **Assets** |  |  |
| Current Assets |  |  |
| Cash | $23748 | $18451 |
| Short-term investments | 81420 | 74082 |
| Trade receivables, net | 72920 | 64510 |
| Gross inventories (Note 4) | 102850 | 113166 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less LIFO reserve | (67886) | (67058) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less excess and obsolescence reserve | (2715) | (3227) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net inventories | 32249 | 42881 |
| Prepaid expenses and other current assets | 10741 | 11680 |
| Total Current Assets | 221078 | 211604 |
| Property, plant and equipment | 511048 | 506799 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less allowances for depreciation | (431950) | (426702) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net property, plant and equipment | 79098 | 80097 |
| Deferred income taxes | 19128 | 19720 |
| Other assets | 29807 | 30576 |
| Total Assets | $349111 | $341997 |

---

<u>Note</u>:

The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

*See notes to condensed consolidated financial statements.* 

STURM, RUGER & COMPANY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Continued)

*(Dollars in thousands, except per share data*)

---

| | | |
|:---|:---|:---|
| | March 28, 2026 | December 31, 2025 |
|  | | (Note) |
| **Liabilities and Stockholders' Equity** |  |  |
| Current Liabilities |  |  |
| Trade accounts payable and accrued expenses | $38314 | $34122 |
| Contract liabilities with customers (Note 3) | 714 |  |
| Product liability | 942 | 964 |
| Employee compensation and benefits | 18597 | 15023 |
| Workers' compensation | 4614 | 4638 |
| Total Current Liabilities | 63181 | 54747 |
| Lease liabilities (Note 5) | 1056 | 1158 |
| Employee compensation | 1513 | 2271 |
| Product liability accrual | 61 | 61 |
| Contingent liabilities (Note 13) |  |  |
| Stockholders' Equity |  |  |
| Common Stock, non-voting, par value $1: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized shares 50,000; none issued |  |  |
| &nbsp;&nbsp;Common Stock, par value $1: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Authorized shares – 40,000,000 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2026 – 24,494,291 issued, |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15,948,066 outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 – 24,490,478 issued, |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15,944,253 outstanding | 24494 | 24490 |
| Additional paid-in capital | 56040 | 55356 |
| Retained earnings | 420897 | 422045 |
| Less: Treasury stock – at cost |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2026 – 8,546,225 shares |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 – 8,546,225 shares | (218131) | (218131) |
| Total Stockholders' Equity | 283300 | 283760 |
| Total Liabilities and Stockholders' Equity | $349111 | $341997 |

---

<u>Note</u>:

The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

*See notes to condensed consolidated financial statements.*

STURM, RUGER & COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED)

*(Dollars in thousands, except per share data)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Net firearms sales | $140896 | $135195 |
| Net castings sales | 460 | 543 |
| Total net sales | 141356 | 135738 |
| Cost of products sold | 113278 | 105843 |
| Gross profit | 28078 | 29895 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling | 9356 | 9413 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 20671 | 12010 |
| Total operating expenses | 30027 | 21423 |
| Operating (loss) income | (1949) | 8472 |
| Other income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 801 | 1038 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (22) | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 1096 | 253 |
| Total other income, net | 1875 | 1275 |
| (Loss) income before income taxes | (74) | 9747 |
| Income taxes | (202) | 1979 |
| Net income and comprehensive income | $128 | $7768 |
| Basic earnings per share | $0.01 | $0.47 |
| Diluted earnings per share | $0.01 | $0.46 |
| Weighted average number of common shares outstanding - Basic | 15945349 | 16623214 |
| Weighted average number of common shares outstanding - Diluted | 16247380 | 16850956 |
| Cash dividends per share | $0.08 | $0.24 |

---

*See notes to condensed consolidated financial statements.*

STURM, RUGER & COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

*(Dollars in thousands)*

 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Common<br> Stock | Additional <br> Paid-in <br> Capital | Retained <br> Earnings | Treasury<br> Stock | Total |
| Balance at December 31, 2025 | $24490 | $55356 | $422045 | $(218131) | $283760 |
| Net income and comprehensive income |  |  | 128 |  | 128 |
| Common stock issued – compensation plans | 4 | (4) |  |  |  |
| Vesting of RSUs |  | (49) |  |  | (49) |
| Dividends paid |  |  | (1276) |  | (1276) |
| Recognition of stock-based compensation expense |  | 737 |  |  | 737 |
| Balance at March 28, 2026 | $24494 | $56040 | $420897 | $(218131) | $283300 |

---

 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Common<br> Stock | Additional<br> Paid-in<br> Capital | Retained<br> Earnings | Treasury<br> Stock | Total |
| Balance at December 31, 2024 | $24468 | $50536 | $436609 | $(192031) | $319582 |
| Net income and comprehensive income |  |  | 7768 |  | 7768 |
| Common stock issued – compensation plans | 5 | (5) |  |  |  |
| Vesting of RSUs |  | (178) |  |  | (178) |
| Dividends paid |  |  | (3992) |  | (3992) |
| Unpaid dividends accrued |  |  | 146 |  | 146 |
| Recognition of stock-based compensation expense |  | 1146 |  |  | 1146 |
| Repurchase of 79,200 shares of common stock |  |  |  | (2991) | (2991) |
| Balance at March 29, 2025 | $24473 | $51499 | $440531 | $(195022) | $321481 |

---

 

*See notes to condensed consolidated financial statements.*

STURM, RUGER & COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(*Dollars in thousands)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| &nbsp;&nbsp;Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $128 | $7768 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6008 | 5571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 737 | 1146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excess and obsolescence inventory reserve | (512) | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on disposal of assets | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 592 | (1576) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade receivables | (8410) | (343) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 11144 | 5740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable and accrued expenses | 4116 | (2281) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities with customers | 714 | 789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | 2816 | (5023) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Product liability | (22) | (58) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses, other assets and other liabilities | 1440 | (628) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities | 18750 | 11145 |
| &nbsp;&nbsp;Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment additions | (4791) | (1124) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from the sale of assets | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of short-term investments | (11375) | (36288) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities of short-term investments | 4037 | 39580 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash (used for) provided by investing activities | (12128) | 2168 |
| &nbsp;&nbsp;Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remittance of taxes withheld from employees related to share-based compensation | (49) | (178) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock |  | (2991) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | (1276) | (3992) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used for financing activities | (1325) | (7161) |
| &nbsp;&nbsp;Increase in cash and cash equivalents | 5297 | 6152 |
| &nbsp;&nbsp;Cash and cash equivalents at beginning of period | 18451 | 10028 |
| &nbsp;&nbsp;Cash and cash equivalents at end of period | $23748 | $16180 |

---

*See notes to condensed consolidated financial statements.*

STURM, RUGER & COMPANY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

*(Dollars in thousands, except per share)*

 

NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended March 28, 2026 may not be indicative of the results to be expected for the full year ending December 31, 2026. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

<u>Organization:</u> 

Sturm, Ruger & Company, Inc. (the "Company") is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 5% of total sales for each of the three month periods ended March 28, 2026 and March 29, 2025, respectively. The Company's design and manufacturing operations are located in the United States and almost all product content is domestic. The Company's firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

The Company also manufactures investment castings made from steel alloys and metal injection molding ("MIM") parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Approximately 1% of sales are from the castings segment.

Principles of Consolidation:

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

Revenue Recognition:

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, *Revenue from Contracts with Customers* ("ASC 606"). Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company's products from the independent distributors. The fulfillment of these no charge products is the Company's responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales.

<u>Fair Value Measurements:</u>

The carrying amounts of financial instruments, including cash, short-term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to the short-term maturity of these items.

The Company's short-term investments consist of United States Treasury instruments, which mature within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund's securities. The NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV.

The fair value of inventory acquired as part of a business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of a business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of a business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of a business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).

<u>Business Combination:</u> 

On July 1, 2025, the Company acquired substantially all of the assets of Anderson Manufacturing ("Anderson") for a total purchase price of $15.8 million in cash, with $15 million having been paid in cash at the closing of the transaction and $0.8 million having been held back from the purchase price for potential repair remediation costs, which will either be applied to repair costs or paid to Anderson. This holdback was included in trade accounts payable and accrued expenses on the Company's Condensed Consolidated Balance Sheet at March 28, 2026.

The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - Business Combinations, which requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their fair value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. The estimates of fair value are based upon assumptions believed to be reasonable, yet are inherently uncertain and, as a result, may differ from actual performance. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill in the period in which such revised estimates are identified. No such adjustments were recorded in the three months ended March 28, 2026.

<u>Use of Estimates:</u> 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

<u>Recent Accounting Pronouncements:</u>

In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03")." This guidance requires the disaggregation of certain expense captions into specified categories in disclosures within the notes to the financial statements to provide enhanced transparency into the expense captions presented on the statement of earnings. It is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. Adoption may be applied either prospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or retrospectively to any or all prior periods presented in the financial statements. The Company is evaluating the impact of this guidance on the Company's related disclosures.

In December 2025, the FASB issued its final ASU which makes improvements to the Accounting Standards Codification in response to feedback from stakeholders. This standard, issued as ASU 2025-12, specifically updates the Codification for a broad range of Topics arising from technical corrections, unintended application of the Codification, clarifications, and other minor improvements. This update is effective for annual reporting periods beginning after December 15, 2026, including interim reporting periods within those annual reporting periods. The Company is currently evaluating the impact of adopting ASU 2025-12. In September 2025, the FASB issued ASU No. 2025-06, "Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal Use Software." The standard modernizes and simplifies guidance for internal-use software costs. This guidance is effective for annual reporting periods beginning after December 15, 2027 including interim reporting periods within those annual reporting periods. The Company is evaluating the impact of this guidance on its Consolidated Financial Statements.

NOTE 3 - REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

The impact of ASC 606 on revenue recognized during the three months ended March 28, 2026 and March 29, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Contract liabilities with customers at beginning of period | $— | $— |
| Revenue deferred | 714 | 789 |
| Revenue recognized |  |  |
| Contract liabilities with customers at end of period | $714 | $789 |

---

As more fully described in the Revenue Recognition section of Note 2, the deferral of revenue and subsequent recognition thereof relates to certain of the Company's sales promotion programs that include the future shipment of free products. The Company expects the remaining deferred revenue from the contract liabilities with customers to be recognized in the second quarter of 2026.

<u>Practical Expedients and Exemptions</u>

The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

NOTE 4 - INVENTORIES

Inventories are valued using the last-in, first-out (LIFO) method. An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs existing at that time. Accordingly, interim LIFO calculations must necessarily be based on management's estimates of expected year-end inventory levels and costs. Because these are subject to many factors beyond management's control, interim results are subject to the final year-end LIFO inventory valuation.

Inventories consist of the following:

---

| | | |
|:---|:---|:---|
| | March 28, 2026 | December 31, 2025 |
| Inventory at FIFO |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Finished products | $8780 | $10993 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Materials and work in process | 94070 | 102173 |
| Gross inventories | 102850 | 113166 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: LIFO reserve | (67886) | (67058) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: excess and obsolescence reserve | (2715) | (3227) |
| Net inventories | $32249 | $42881 |

---

NOTE 5 - LEASED ASSETS

The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02, *Leases (Topic 842)*. The Company's lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.

Under the provisions of ASU 2016-02, the Company records right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the Condensed Consolidated Balance Sheet as of March 28, 2026:

---

| | | |
|:---|:---|:---|
| | Balance Sheet Line Item | March 28, 2026 |
| Right-of-use assets | Other assets | $1651 |
| Operating lease liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion | Trade accounts payable and accrued expenses | $595 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncurrent portion | &nbsp;&nbsp;Lease liabilities | 1056 |
| Total operating lease liabilities |  | $1651 |

---

The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.

The Company's leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities.

Certain of the Company's lease agreements contain renewal options at the Company's discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs.

The table below includes cash paid for the Company's operating lease liabilities, other non-cash information, weighted average remaining lease term and weighted average discount rate:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Cash paid for amounts included in the measurement of lease liabilities | $154 | $180 |
| Cash amounts paid for short-term leases | $123 | $81 |
| Right-of-use assets obtained in exchange for lease liabilities | $— | $— |
| Weighted average remaining lease term (years) | 5.89 | 7.4 |
| Weighted average discount rate | 8.0% | 8.0% |

---

The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the Condensed Consolidated Balance Sheet as of March 28, 2026:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Remainder of 2026 | $578 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2027 | 324 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2028 | 230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2029 | 160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2030 | 160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thereafter | 640 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total undiscounted future minimum lease payments | 2092 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Difference between undiscounted lease payments & the present value of future lease payments | (441) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating lease liabilities | $1651 |

---

NOTE 6 - LINE OF CREDIT

On June 6, 2024, the Company amended its existing $40 million unsecured revolving line of credit agreement with a bank, which now expires January 7, 2028. Borrowings under this new facility bear interest at the applicable Secured Overnight Financing Rate (SOFR), plus 150 basis points, plus an additional adjustment of eight basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At March 28, 2026, the Company was in compliance with the terms and covenants of the credit facility and the line of credit was unused.

NOTE 7 - EMPLOYEE BENEFIT PLANS

The Company sponsors a 401(k) plan that covers substantially all employees. The Company matches a certain portion of employee contributions using the safe harbor guidelines contained in the Internal Revenue Code. Expenses related to these matching contributions totaled $1.1 million and $1.2 million for the three months ended March 28, 2026 and March 29, 2025, respectively. The Company plans to contribute approximately $3.0 million to the plan in matching employee contributions during the remainder of 2026.

In addition, the Company provided supplemental discretionary contributions to the 401(k) plan totaling $1.8 million and $2.0 million for the three months ended March 28, 2026 and March 29, 2025, respectively. The Company plans to contribute approximately $4.5 million in supplemental contributions to the plan during the remainder of 2026.

NOTE 8 - INCOME TAXES

The Company's 2026 and 2025 effective tax rates differ from the statutory federal tax rate due principally to the availability of research and development tax credits, state income taxes, and the nondeductibility of certain executive compensation. The Company's effective income tax rate was 271.6% and 20.3% for the three months ended March 28, 2026 and March 29, 2025, respectively. The discrete nature of these tax credits yields an effective tax rate for the period that is not meaningful at low earnings levels.

The Company did not make any income tax payments during the three months ended March 28, 2026. Income tax payments totaled $2.0 million for the three months ended March 29, 2025.

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2021.

The Company does not believe it has included any "uncertain tax positions" in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

NOTE 9 - EARNINGS PER SHARE

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Numerator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $128 | $7768 |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average number of common shares outstanding – Basic | 15945349 | 16623214 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dilutive effect of options and restricted stock units outstanding under the Company's employee compensation plans | 302031 | 227742 |
| Weighted average number of common shares outstanding – Diluted | 16247380 | 16850956 |

---

The dilutive effect of outstanding options and restricted stock units is calculated using the treasury stock method. There were no stock options that were anti-dilutive and therefore not included in the diluted earnings per share calculation.

NOTE 10 - COMPENSATION PLANS

In May 2017, the Company's stockholders approved the 2017 Stock Incentive Plan (the "2017 SIP") under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors*.* The Company reserved 750,000 shares for issuance under the 2017 SIP.

In June 2023, the Company's stockholders approved the 2023 Stock Incentive Plan (the "2023 SIP") under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors*.* The Company reserved 1,000,000 shares for issuance under the 2023 SIP, of which 304,000 shares remain available for future grants as of March 28, 2026. Any shares remaining from the 2017 SIP will be available for future grants under the terms of the 2023 SIP. As of March 28, 2026, approximately 144,000 shares remained unawarded from the 2017 SIP. Since the stockholder approval of the 2023 SIP, no additional awards have been or will be granted under the 2017 SIP. Previously granted and outstanding awards under the 2017 SIP will remain subject to the terms of the 2017 SIP.

<u>Restricted Stock Units</u>

The Company grants performance-based and retention-based restricted stock units to senior employees. The vesting of the performance-based awards is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors and a three-year vesting period. The retention-based awards are subject only to a three-year vesting period. There were 162,689 restricted stock units issued during the three months ended March 28, 2026. Total compensation costs related to these restricted stock units are $6.4 million.

Compensation costs related to all outstanding restricted stock units recognized in the statements of income aggregated $2.3 million and $2.1 million for the three months ended March 28, 2026 and March 29, 2025, respectively.

NOTE 11 - OPERATING SEGMENT INFORMATION

The Company has two reportable segments: firearms and castings. The firearms segment manufactures and sells rifles, shotguns, pistols, and revolvers principally to a select number of independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.

Selected operating segment financial information follows:

---

| | | |
|:---|:---|:---|
| (in thousands) | Three Months Ended | Three Months Ended |
|  | March 28, 2026 | March 29, 2025 |
| Net Sales |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $140896 | $135195 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unaffiliated | 460 | 543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 4863 | 7222 |
|  | 5323 | 7765 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eliminations | (4863) | (7222) |
|  | $141356 | $135738 |
| Costs of Goods Sold |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $112663 | $105254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unaffiliated | 615 | 589 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 4863 | 7222 |
|  | 5478 | 7811 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eliminations | (4863) | (7222) |
|  | $113278 | $105843 |
| Gross Profit (Loss) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $28233 | $29941 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings | (155) | (46) |
|  | $28078 | $29895 |
| Operating Income (Loss) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $(1582) | $8655 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings | (367) | (183) |
|  | $(1949) | $8472 |
| Income (Loss) Before Income Taxes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $(1315) | $8758 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings | (367) | (145) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate | 1608 | 1134 |
|  | $(74) | $9747 |

---

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Depreciation |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Firearms | $5438 | $4988 |
| &nbsp;&nbsp;&nbsp;&nbsp;Castings | 352 | 347 |
|  | $5790 | $5335 |
| Capital Expenditures |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Firearms | $4780 | $1034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Castings | 11 | 90 |
|  | $4791 | $1124 |

---

---

| | | |
|:---|:---|:---|
| | March 28, 2026 | December 31, 2025 |
| Identifiable Assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Firearms | $204468 | $205061 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Castings | 7440 | 7659 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate | 137203 | 129277 |
|  | $349111 | $341997 |
| Goodwill |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Firearms | $3445 | $3445 |
| &nbsp;&nbsp;&nbsp;&nbsp;Castings | 209 | 209 |
|  | $3654 | $3654 |

---

NOTE 12 - RELATED PARTY TRANSACTIONS

The Company contracts with the National Rifle Association ("NRA") for some of its promotional and advertising activities. One of the Company's former Directors also served as a Director on the Board of the NRA through October 2025. In 2026, the NRA is no longer considered a related party. Payments made to the NRA in the three months ended March 29, 2025 totaled $0.3 million.

The Company is a member of the National Shooting Sports Foundation ("NSSF"), the firearm industry trade association. Payments made to the NSSF in the three months ended March 28, 2026 and March 29, 2025 totaled $0.1 million and $0.1 million, respectively. One of the Company's Directors also serves on the Board of the NSSF.

NOTE 13 - CONTINGENT LIABILITIES

As of March 28, 2026, the Company was a defendant in seven (7) lawsuits and is aware of certain other claims. The lawsuits generally fall into the categories of municipal litigation, unfair trade practices, product liability, and trademark litigation. One (1) product liability matter and one (1) employment matter were fully and finally resolved during the quarter. Material matters and developments are discussed in turn below.

<u>Municipal Litigation</u>

Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. There are three pending lawsuits of this type: the *City of Gary*, filed in Indiana State Court in 1999; *The City of Buffalo*, filed in the Supreme Court of the State of New York for Erie County on December 20, 2022; and *The City of Rochester*, filed in the Supreme Court for the State of New York for Monroe County on December 21, 2022, each of which is described in more detail below.

The *City of Gary* seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages as well as nuisance abatement and/or injunctive relief to change the design, manufacture, marketing and distribution practices of the various Defendants. The Complaint alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products. After a long procedural history, the Indiana Court of Appeals recently reversed the trial court and ordered dismissal of the case. The Indiana Court of Appeals denied the City's request for rehearing, and the City petitioned the Indiana Supreme Court to review the matter. The Defendants and the State of Indiana opposed the petition. The parties are awaiting the Indiana Supreme Court's decision on the petition.

*The City of Buffalo v. Smith & Wesson Brands, Inc., et al.* and *The City of Rochester v. Smith & Wesson Brands, Inc., et al* were filed on consecutive days in New York State Court, naming a number of firearm manufacturers, distributors, and retailers as Defendants, including the Company. The complaints are virtually identical and, relying primarily on New York's General Business Law §898-b, generally allege that the criminal misuse of firearms in their cities is the result of the manufacturing, sales, marketing, and distribution practices of the Defendants. These matters seek unspecified compensatory damages, creation of an abatement fund, punitive damages and other relief. Both matters were timely removed to federal court and were consolidated for pretrial purposes only. Those matters were stayed pending the outcome of a different matter that challenges New York's law, which was decided earlier this year. The Defendants moved to dismiss the cases and in response, the Cities amended their complaints to dismiss many defendants and amend the allegations against the remaining defendants, including the Company, to allege violation of N.Y. Gen. Bus. Law § 898-b(2) and Common Law Public Nuisance. The Defendants have moved to dismiss the amended complaint.

<u>Unfair Trade Practices</u>

*Estate of Suzanne Fountain v. Sturm, Ruger & Co., Inc.,* and *Estate of Nevin Stanisic v. Sturm, Ruger & Co., Inc.* are pending in Connecticut state court and arise out of the criminal shootings at the King Soopers supermarket in Boulder, Colorado on March 22, 2021. The Complaints allege, among other things, that the Company's advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act ("CUPTA") and seek damages for the alleged wrongful death of the victims.

The *Fountain* and *Stanisic* cases were consolidated for discovery purposes only and transferred by the court to the Complex Litigation Docket. The parties have commenced discovery, and on April 20, 2026, the Company filed a Motion for Choice of Law Determination and/or for Summary Judgment, seeking application of Colorado law to the matter or, in the alternative, summary judgment on the plaintiff's CUTPA claims.

Product Liability

 

The Company is a defendant in one traditional product liability matter. *Fortenberry v. Sturm, Ruger & Company, Inc.* was served on July 11, 2025 and is pending in the Circuit Court of Arkansas County, Arkansas Northern District, Civil Division. This complaint alleges wrongful death arising out of an alleged product design defect in an "old model" Ruger Single-Six revolver. Discovery is underway in that matter.

Trademark Litigation

The Company is a defendant in *FN Herstal, et al. v. Sturm, Ruger & Company, Inc.*, which is pending in North Carolina. The Complaint alleges that the Company's use of the initialism "SFAR" in connection with the marketing of its Small Frame Autoloading Rifle infringes the Plaintiffs' SCAR trademark. The Complaint alleges violations of the Lanham Act and the North Carolina Unfair and Deceptive Trade Practices Act, as well as trademark infringement under North Carolina common law. The parties are awaiting decision on dispositive motions.

<u>Summary of Claimed Damages and Explanation of Product Liability Accruals</u>

Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage.

For product liability claims made between July 10, 2000 and August 31, 2024, insurance coverage was provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain claims brought by governments or municipalities, which are excluded from coverage. Insurance coverage was not renewed with incumbent carriers effective September 1, 2024. Rather, the Company established a wholly-owned captive insurance company for claims made on or after September 1, 2024.

The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company's financial results for a particular period.

Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as the lawsuits and claims develop, the timing of which may vary greatly from case to case. A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.

Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.

In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; *i.e.*, an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.

Often, a Complaint does not specify the amount of damages being sought and a range of reasonably possible losses relating to unfavorable outcomes cannot be made. The dollar amount of damages claimed at December 31, 2025, December 31, 2024 and December 31, 2023 was *de minimis*.

NOTE 14 – STOCKHOLDER RIGHTS PLAN

On October 14, 2025, the Company's Board of Directors (the "Board") approved the adoption of a limited-duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective October 14, 2025 ("Effective Date") and will expire on October 13, 2026. The Board, in consultation with its advisors, adopted the Rights Plan in response to the public announcement by Beretta Holding S.A. ("Beretta") that it had accumulated a significant economic interest in Ruger's common stock and intends to engage in discussions with the Company regarding "potential areas of operational and strategic collaborations." The Rights Plan is intended to ensure that the Board remains in the best position to perform its fiduciary duties and to enable all stockholders to receive fair and equal treatment.

Pursuant to the Rights Plan, the Company has authorized and declared a dividend of one common share purchase right (a "Right") for each share of Common Stock that is outstanding at the close of business on October 24, 2025 and that may become outstanding between such date and the Distribution Date (as defined below) or the earlier Expiration Date (as defined in the Rights Plan). The Rights are not exercisable until after the Distribution Date. After the Distribution Date, each Right will be exercisable to purchase from the Company one share of Common Stock at a purchase price of $200 per share of Common Stock, subject to adjustment.

The "Distribution Date" means the close of business on the business day immediately following the earlier of (i) the Flip-In Date (as defined in the Rights Plan) or (ii) 10 business days after the date (prior to such time as any person becomes an Acquiring Person), if any, as may be determined by action of the Board, in its sole discretion, following the commencement of, or public announcement of an intention to commence, a tender or exchange offer the consummation of which would result in any person or group of affiliated or associated persons becoming an Acquiring Person.

An "Acquiring Person" means any person who becomes the beneficial owner of 10% or more of the outstanding shares of Common Stock of the Company, subject to certain specified exceptions set forth in the Rights Plan, including passive institutional investors. The Rights Plan also provides that any person who would otherwise be deemed an Acquiring Person as of the date of the adoption of the Rights Plan will not be deemed to be an Acquiring Person for so long as such person does not acquire, subject to certain specified exceptions, beneficial ownership of any additional shares of Common Stock following adoption of the Rights Plan.

If the Rights become exercisable, all holders of Rights (other than the person or group triggering the Rights Plan, whose Rights would become void) will be entitled to acquire shares of Common Stock at a 50% discount to the then-current market price or the Company may exchange each Right held by such holders for one share of Common Stock.

The Rights will expire at the close of business on the day before the first anniversary of the date of the Rights Plan, unless the Rights Plan is amended to change the Final Expiration Date (as defined in the Rights Plan) or the Rights are earlier redeemed or exchanged by the Company.

Pursuant to the Beretta Agreement (as defined below), the Company has undertaken to make certain amendments to the Rights Plan, upon the satisfaction of certain regulatory conditions precedent, as described in the Beretta Agreement.

NOTE 15 - SUBSEQUENT EVENTS

On April 30, 2026, the Board of Directors authorized a dividend of 11¢ per share, for stockholders of record as of May 14, 2026, payable on May 29, 2026.

On May 1, 2026, the Company and Beretta Holding S.A. ("Beretta") entered into that certain Agreement (the "Beretta Agreement"), concerning, amongst other things, Company board representation, a tender offer to be launched by Beretta for Company Common Stock, potential future commercial collaboration between Beretta and the Company, certain regulatory matters, certain amendments to the Rights Plan, voting commitments to be undertaken by Beretta, and certain other matters. The foregoing summary of the Beretta Agreement is qualified in its entirety by the Beretta Agreement, which is attached as Exhibit 10.1 to the Form 10-Q.

The Company has evaluated events and transactions occurring subsequent to March 28, 2026 and determined that there were no other unreported events or transactions that would have a material impact on the Company's results of operations or financial position.

### ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
**Company Overview**

Sturm, Ruger & Company, Inc. (the "Company") is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 5% of total sales for each of the three month periods ended March 28, 2026 and March 29, 2025. The Company's design and manufacturing operations are located in the United States and almost all product content is domestic. The Company's firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

The Company also manufactures investment castings made from steel alloys and metal injection molding ("MIM") parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Less than 1% of sales are from the castings segment.

Orders for many models of firearms from the independent distributors tend to be stronger in the first quarter of the year and weaker in the third quarter of the year. This is due in part to the timing of the distributor show season, which occurs during the first quarter.

**Results of Operations**

During the three months ended March 28, 2026, the Company executed on its Ruger 2030 plan – strengthening operational responsiveness, enhancing the product portfolio and positioning the Company for sustainable long-term growth. Activity in the quarter included:

· The Company's Board of Directors advancing a deliberate and independent refreshment process, which saw the retirement of three existing directors and the addition of three new directors with relevant operational, industrial and strategic expertise while maintaining continuity during a period of leadership transition.

· The appointment of a new CFO in April of 2026, along with other ongoing organizational realignment designed to improve efficiency and effectiveness.

· The generation of $18.8 million in cash from operations, versus $11.1 million over the same period last year.

· New product sales reaching $51.6 million, or 41%, of total firearm sales for the quarter. New product sales include only major new products that were introduced in the past two years and include the RXM pistol, Marlin 1894 lever-action rifles, American Centerfire Rifle Generation II, Glenfield rifles, Harrier rifles and the Ruger Red Label III Shotgun.

· The increase of estimated sell-through of the Company's products from the independent distributors to retailers by 3.2% from Q1 2025, exceeding a 1.6% increase in adjusted NICS during the same period. At the same time, compared to the first quarter of 2025, the Company's finished goods inventories decreased 95,800 units while distributors' inventories decreased 26,400 units, reflecting strong retail pull through of the Company's new products.

· The Hebron Facility is operating at target capacity, as of March 28, 2026.

As announced on May 4, 2026, Ruger and Beretta Holding entered an Agreement that reflects a shared commitment to long-term value creation, constructive engagement, and stability for Ruger's shareholders, employees, customers and industry partners. Throughout that process, the Company took actions to protect the interests of all shareholders and to maintain focus on executing its long-term strategy. These efforts resulted in professional fees and advisory costs totaling $3.2 million during the quarter. These costs are largely non-recurring in nature and do not reflect the underlying performance of the core business. With the Agreement now in place, the Company expects these costs to be limited in duration, though some additional expenses may be incurred in the near term.

Additionally, in February, the Company executed a reduction-in-force as part of broader efforts to structurally align the organization to strategic priorities and the future operating model. These actions are consistent with the changes outlined in the 2026 Plan and, more broadly, the Ruger 2030 framework. The moves improve efficiency, enhance accountability and position the Company for long-term profitable growth. The associated severance and related cost of $2.5 million were recognized in the quarter and are not indicative of ongoing operations.

As a result of the factors listed above, the results of operations for the three month period ending March 28, 2026 were negatively impacted, on a non-GAAP basis, by $0.26 per share (see the Non-GAAP Financial Performance Measures below.) The impact was as follows:

· Additional general and administrative expenses of $3.2 million, or $0.15 per share, related to the proxy contest with Beretta.

· Increased general and administrative expenses of $2.5 million, or $0.11 per share, related to the leadership/governance transition and organizational realignment

<u>Demand</u>

The estimated unit sell-through of the Company's products from the independent distributors to retailers increased 3% in the first three months of 2026 compared to the prior year period. For the same period, National Instant Criminal Background Check System ("NICS") background checks (as adjusted by the National Shooting Sports Foundation ("NSSF")) increased 2%. Estimated sell-through from the independent distributors to retailers and total adjusted NICS background checks for the trailing five quarters follow:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 2026 | 2025 | 2025 | 2025 | 2025 |
|  | Q1 | Q4 | Q3 | Q2 | Q1 |
| Estimated Units Sold from Distributors to Retailers (1) | 376400 | 473800 | 370600 | 328500 | 364700 |
| Total adjusted NICS Background Checks (thousands) (2) | 3877 | 4295 | 3249 | 3251 | 3817 |

---

<sup>(1)</sup> The estimates for each period were calculated by taking the beginning inventory at the distributors, plus shipments from the Company to distributors during the period, less the ending inventory at distributors. These estimates are only a proxy for actual market demand as they:

· Rely on data provided by independent distributors that are not verified by the Company,

· Do not consider potential timing issues within the distribution channel, including goods-in-transit, and

· Do not consider fluctuations in inventory at retail.

<sup>(2)</sup> NICS background checks are performed when the ownership of most firearms, either new or used, is transferred by a Federal Firearms Licensee. NICS background checks are also performed for permit applications, permit renewals, and other administrative reasons.

The adjusted NICS data presented above was derived by the NSSF by subtracting out NICS checks that are not directly related to the sale of a firearm, including checks used for concealed carry ("CCW") permit application checks, as well as checks on active CCW permit databases. The adjusted NICS checks represent less than half of the total NICS checks.

Adjusted NICS data can be impacted by changes in state laws and regulations and any directives and interpretations issued by governmental agencies.

<u>Orders Received and Ending Backlog</u>

The Company uses the estimated unit sell-through of its products from the independent distributors to retailers, along with inventory levels at the independent distributors and at the Company, as the key metrics for planning production levels. The Company generally does not use the orders received or ending backlog for planning production levels.

The units ordered, value of orders received, average sales price of units ordered, and ending backlog for the trailing five quarters are as follows (dollars in millions, except average sales price):

(All amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns.)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 2026 | 2025 | 2025 | 2025 | 2025 |
|  | Q1 | Q4 | Q3 | Q2 | Q1 |
| Units Ordered | 525300 | 550300 | 286500 | 355900 | 410000 |
| Orders Received | $211.0 | $160.2 | $87.9 | $113.7 | $154.0 |
| Average Sales Price of Units Ordered | $402 | $322 | $307 | $319 | $376 |
| Ending Backlog | $329.7 | $285.0 | $227.0 | $263.1 | $275.2 |
| Average Sales Price of Ending Unit Backlog | $475 | $524 | $543 | $534 | $552 |

---

<u>Production</u>

The Company reviews the estimated sell-through from the independent distributors to retailers, as well as inventory levels at the independent distributors and at the Company to plan production levels. The Company's overall production in the first quarter of 2026 decreased 4% from the fourth quarter of 2025*.* 

<u>Summary Unit Data</u>

Firearms unit data for the trailing five quarters are as follows (dollar amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 2026 | 2025 | 2025 | 2025 | 2025 |
|  | Q1 | Q4 | Q3 | Q2 | Q1 |
| Units Ordered | 525300 | 550300 | 286500 | 355900 | 410000 |
| Units Produced | 342800 | 357800 | 344900 | 381600 | 372000 |
| Units Shipped | 375600 | 424400 | 361600 | 361400 | 356700 |
| Average Sales Price of Units Shipped | $375 | $355 | $336 | $349 | $379 |
| Ending Unit Backlog | 693600 | 543900 | 418000 | 493100 | 498600 |

---

<u>Inventories</u>

During the first three months of 2026, the Company's finished goods inventory decreased by 32,800 units and distributor inventories of the Company's products decreased by 800 units.

Inventory unit data for the trailing five quarters follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 2026 | 2025 | 2025 | 2025 | 2025 |
|  | Q1 | Q4 | Q3 | Q2 | Q1 |
| Company Inventory | 34700 | 67500 | 134100 | 150700 | 130500 |
| Distributor Inventory (1) | 161500 | 162300 | 211700 | 220700 | 187900 |
| Total Inventory (2) | 196200 | 229800 | 345800 | 371400 | 318400 |

---

<sup>(1)</sup> Distributor ending inventory is provided by the Company's independent distributors. These numbers do not include goods-in-transit inventory that has been shipped from the Company but not yet received by the distributors.

<sup>(2)</sup> This total does not include inventory at retailers. The Company does not have access to data on retailer inventories of the Company's products.

<u>Net Sales, Cost of Products Sold, and Gross Profit</u>

Net sales, cost of products sold, and gross profit data for the three months ended (dollars in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | March 28, 2026 | March 29, 2025 | Change | % Change |
| Net firearms sales | $140.9 | $135.2 | $5.7 | 4.2% |
| Net castings sales | 0.5 | 0.5 |  | (15.3%) |
| Total net sales | 141.4 | 135.7 | 5.7 | 4.1% |
| Cost of products sold | 113.3 | 105.8 | 7.5 | 7.0% |
| Gross profit | $28.1 | $29.9 | $(1.8) | (7.3%) |
| Gross margin | 19.9% | 22.0% | (2.1%) | (9.5%) |

---

Total consolidated net sales and net firearms sales increased slightly for the three months ended March 28, 2026. Sales of new products, including the RXM pistol, Marlin 1894 lever-action rifles, American Centerfire Rifle Generation II, Glenfield rifles, Harrier rifles, and the Ruger Red Label III Shotgun represented $51.6 million or 41% of firearm sales in the three months ended March 28, 2026. New product sales include only major new products that were introduced in the past two years.

The decreased gross profit for the three months ended March 28, 2026 is attributable to unfavorable leveraging of fixed costs resulting from decreased production, exacerbated by the $0.8 million of deferred revenue related to sales promotions.

The decrease in gross margin for the three months ended March 28, 2026 is attributable to the aforementioned factors.

<u>Selling and General and Administrative Expenses</u>

Selling and general and administrative expenses data for the three months ended (dollars in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | March 28, 2026 | March 29, 2025 | Change | % Change |
| Selling expenses | $9.3 | $9.4 | $(0.1) | (0.6%) |
| General and administrative expenses | 20.7 | 12.0 | 8.7 | 72.1% |
| Total operating expenses | $30.0 | $21.4 | $8.6 | 40.2% |

---

Selling expenses for the three months ended March 28, 2026 were substantially comparable to the corresponding period in the prior year.

The increase in general and administrative expenses for the three months ended March 28, 2026 was primarily attributable to $3.2 million in legal fees incurred related to the Beretta Strategic Cooperation Agreement, $2.5 million in severance costs, increased to share based compensation, which included a one-time non-recurring expense of $1.7 million, and increased professional service costs.

<u>Other Income</u>

Other income data for the three months ended (dollars in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | March 28, 2026 | March 29, 2025 | Change | % Change |
| Other income | $1.9 | $1.3 | $0.6 | 47.1% |

---

The increase in other income for the three months ended March 28, 2026 was attributable to increased royalty income.

<u>Income Taxes and Net Income</u>

The Company's 2026 and 2025 effective tax rates differ from the statutory federal tax rate due principally to research and development tax credits, state income taxes and the nondeductibility of certain executive compensation. The reduction in 2026 earnings increased the impact of these items. The Company's effective income tax rate was 271.6% and 20.3% for the three months ended March 28, 2026 and March 29, 2025, respectively. The discrete nature of these tax credits yields an effective tax rate for the period that is not meaningful at low earnings levels.

As a result of the foregoing factors, consolidated net income was $0.1 million for the three months ended March 28, 2026, a decrease of 98.4% from $7.8 million in the comparable prior year period.

**Non-GAAP Financial Performance Measures**

In an effort to provide investors with additional information regarding its financial results, the Company refers to various United States generally accepted accounting principles ("GAAP") financial measures and two supplemental non-GAAP financial performance measures, Adjusted EBITDA and Adjusted EBITDA margin, which management believes provides useful information to investors. These non-GAAP financial performance measures may not be comparable to similarly titled financial performance measures being disclosed by other companies. In addition, the Company believes that these non-GAAP financial performance measures have limitations as analytical tools, and, accordingly, should be considered in addition to, and not in lieu of, GAAP financial measures. The presentation of Adjusted EBITDA should not be construed to imply that the Company's future results will not be affected by unusual or non-recurring items.

The Company believes that Adjusted EBITDA and Adjusted EBITDA margin are useful to understanding its operating results and the ongoing performance of its underlying business, as Adjusted EBITDA assists investors in comparing the Company's performance across reporting periods on a consistent basis by excluding items that the Company does not believe are indicative of its operating performance. The Company believes that this reporting provides better transparency and comparability to its operating results. The Company uses both GAAP and non-GAAP financial measures to evaluate the Company's financial performance.

The Company defines Adjusted EBITDA as earnings before interest, taxes, and depreciation and amortization (EBITDA), as further adjusted to eliminate the impact of certain items that the Company does not consider indicative of its ongoing operating performance, as itemized below. Specifically, the Company calculates Adjusted EBITDA by (i) adding the amount of interest expense, income tax expense, and depreciation and amortization expenses that have been deducted from net income back into net income, (ii) subtracting the amount of interest income that was included in net income from net income, (iii) subtracting income tax benefits, (iv) adding the amount of extraordinary cash and non-cash, non-operating expenses, and (v) subtracting non-recurring income or non-recurring gains that do not contribute directly to management's evaluation of its operating results. The Company calculates Adjusted EBITDA margin by dividing Adjusted EBITDA by total net sales.

Adjusted EBITDA was $10.9 million for the three months ended March 28, 2026, a decrease of 23.9% from $14.3 million in the comparable prior year period.

Non-GAAP Reconciliation – Adjusted EBITDA

<u>Adjusted EBITDA</u>

*(Unaudited, dollars in thousands)*

---

| | | |
|:---|:---|:---|
| | Three Months Ended | Three Months Ended |
| | March 28, 2026 | March 29, 2025 |
| Net income | $128 | $7768 |
| Income tax (benefit) expense | (202) | 1979 |
| Depreciation and amortization expense | 6008 | 5571 |
| Interest income | (801) | (1038) |
| Interest expense | 22 | 16 |
| Stockholder rights costs (a) | 3200 |  |
| Severance costs (b) | 2523 |  |
| Adjusted EBITDA | $10878 | $14296 |
| Adjusted EBITDA margin | 7.7% | 10.5% |
| Net income margin | 0.1% | 5.7% |

---

(a) Costs incurred in engaging with Beretta Holding S.A. ("Beretta") on, amongst other things, Beretta's ownership of Company Common Stock, the Rights Plan, negotiations concerning potential strategic cooperation between the Company and Beretta, and in engaging a proxy solicitation firm and preparing a preliminary proxy statement associated with the 2026 Annual Meeting.

(b) Costs incurred associated severance and related costs as part of an executed reduction-in-force as part of broader efforts to structurally align the organization to strategic priorities and the future operating model and are not indicative of ongoing operations

**Financial Condition**

Liquidity and Capital Resources

At the end of the first quarter of 2026, the Company's cash and short-term investments totaled $105.2 million. Pre-LIFO working capital of $225.4 million, less the LIFO reserve of $67.9 million, resulted in working capital of $157.5 million and a current ratio of 3.5 to 1.

Operations

Cash provided by operating activities was $18.8 million for the three months ended March 28, 2026, compared to $11.1 million for the comparable prior year period. The increase in cash provided in the three months ended March 28, 2026 is primarily attributable to decreased inventory, lower net payouts of accrued employee compensation and benefits, and the lesser reduction in accounts payable and accrued expenses, and increases to prepaid expenses and other current assets in the three months ended March 28, 2026, partially offset by the decrease in net income and decreased collections of trade receivables in the three months ended March 28, 2026.

Third parties supply the Company with various raw materials for its firearms and castings, such as steel, fabricated steel components, walnut, birch, beech, maple and laminated lumber for rifle stocks, wax, ceramic material, metal alloys, various synthetic products and other component parts. A limited supply of these materials in the marketplace can result in increases to purchase prices and adversely affect production levels. If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company's manufacturing processes could be interrupted and the Company's financial condition or results of operations could be materially adversely affected.

Investing and Financing

Capital expenditures for the three months ended March 28, 2026 totaled $4.8 million, an increase from $1.1 million in the comparable prior year period. In 2026, the Company expects capital expenditures related to new product introductions and upgrades to its manufacturing equipment and facilities could range from $20 million to $30 million. Actual capital expenditures could vary significantly from the projected amounts due to the timing of capital projects. The Company finances, and intends to continue to finance, all of these activities with funds provided by operations and current cash and cash equivalents.

Dividends of $1.3 million were paid during the three months ended March 28, 2026. The Company has financed its dividends with cash provided by operations and current cash. The quarterly dividend varies every quarter because the Company pays a percentage of earnings rather than a fixed amount per share. The Company's practice is to pay a dividend of approximately 40% of net income.

On April 30, 2026, the Company's Board of Directors authorized a dividend of 11¢ per share to stockholders of record on May 14, 2026, payable on May 29, 2026. This dividend is approximately 40% of adjusted diluted earnings of 27¢ per share for the first quarter of 2026. The payment of future dividends depends on many factors, including internal estimates of future performance, then-current cash and short-term investments, and the Company's need for funds.

As of March 28, 2026, the Company had $39.6 million of United States Treasury instruments which mature within one year. The Company also invests available cash in a bank-managed money market fund that invests exclusively in United States Treasury instruments which mature within one year. At March 28, 2026, the Company's investment in this money market fund totaled $41.8 million.

During the three months ended March 28, 2026 the Company did not purchase any shares of its common stock for in the open market. As of March 28, 2026, $14.3 million remained authorized for future stock repurchases.

Based on its unencumbered assets, the Company believes it has the ability to raise cash through the issuance of short-term or long-term debt. The Company's unsecured $40 million credit facility, which expires on January 7, 2028, was unused at March 28, 2026.

<u>Other Operational Matters</u>

In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to workplace safety, firearms serial number tracking and control, waste disposal, air emissions and water discharges into the environment. The Company believes that it is generally in compliance with applicable Bureau of Alcohol, Tobacco, Firearms & Explosives, environmental, and safety regulations and the outcome of any proceedings or orders will not have a material adverse effect on the financial position or results of operations of the Company. If these regulations become more stringent in the future and the Company is not able to comply with them, such noncompliance could have a material adverse impact on the Company.

The Company has 13 independent distributors that service the domestic commercial market. Additionally, the Company has 39 and 26 distributors servicing the export and law enforcement markets, respectively.

The Company self-insures a significant amount of its product liability, workers' compensation, medical, and other insurance. It also carries significant deductible amounts on various insurance policies. In September 2024, the Company did not renew its product liability coverage with its incumbent carriers and established a wholly-owned captive insurance company for claims made on or after September 1, 2024.

The Company expects to realize its deferred tax assets through tax deductions against future taxable income.

On March 27, 2026, the Company announced that Thomas A. Dineen would step down from his role as Chief Financial Officer of Sturm, Ruger & Company, Inc. on March 31, 2026. On April 1, 2026, Andrew T. Wieland succeeded Mr. Dineen as Chief Financial Officer of the Company and also became a Senior Vice President of the Company.

<u>Adjustments to Critical Accounting Policies</u>

The Company has not made any adjustments to its critical accounting estimates and assumptions described in the Company's 2025 Annual Report on Form 10-K filed on March 2, 2026, or the judgments affecting the application of those estimates and assumptions.

<u>Forward-Looking Statements and Projections</u>

The Company may, from time to time, make forward-looking statements and projections concerning future expectations. Such statements are based on current expectations and are subject to certain qualifying risks and uncertainties, such as market demand, sales levels of firearms, anticipated castings sales and earnings, the need for external financing for operations or capital expenditures, the results of pending litigation against the Company, the impact of future firearms control and environmental legislation, and accounting estimates, any one or more of which could cause actual results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publish revised forward-looking statements to reflect events or circumstances after the date such forward-looking statements are made or to reflect the occurrence of subsequent unanticipated events.

### ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The interest rate market risk implicit to the Company at any given time is typically low, as the Company does not have significant exposure to changing interest rates on invested cash. There has been no material change in the Company's exposure to interest rate risks during the three months ended March 28, 2026.

### ITEM 4. CONTROLS AND PROCEDURES
<u>Evaluation of Disclosure Controls and Procedures</u>

The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures (the "Disclosure Controls and Procedures"), as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of March 28, 2026.

Based on that evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of March 28, 2026, such Disclosure Controls and Procedures are effective to ensure that information required to be disclosed in the Company's periodic reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer or persons performing similar functions, as appropriate, to allow timely decisions regarding disclosure.

The Company's Chief Executive Officer and Chief Financial Officer have further concluded that, as of March 28, 2026, there have been no material changes in the Company's internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 28, 2026 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

The effectiveness of any system of internal controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that the Disclosure Controls and Procedures will detect all errors or fraud. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the internal control system will be attained.

---

| | |
|:---|:---|
| PART II. | OTHER INFORMATION |

---

### ITEM 1. LEGAL PROCEEDINGS
The nature of the legal proceedings against the Company is discussed at Note 13 to the financial statements, which are included in this Form 10-Q.

The Company has reported all cases instituted against it through December 31, 2025, and the results of those cases, where terminated, to the SEC on its previous Form 10-Q and 10-K reports, to which reference is hereby made.

There were no lawsuits formally instituted against the Company during the three months ending March 28, 2026.

During the three months ending March 28, 2026, the previously reported case of *Thompson v. Sturm, Ruger & Company, Inc.*, was withdrawn by the plaintiff.

### ITEM 1A. RISK FACTORS
During the three months ended March 28, 2026, there were no material changes in the Company's risk factors from the information provided in Item 1A. Risk Factors included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

### ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The Company did not purchase any shares of its common stock during the three months ended March 28, 2026. The Company was authorized by the Board of Directors to repurchase up to $100 million of the Company's common stock under a share repurchase program announced on May 8, 2017. As of March 28, 2026, $85.7 million had been used and approximately $14.3 million remained authorized for share repurchases.

### ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable

### ITEM 4. MINE SAFETY DISCLOSURES
Not applicable

### ITEM 5. OTHER INFORMATION
<u>Rule 10b5-1 Trading Plans</u>

There were no contracts, instructions or written plans for the purchase and sale of the Company's securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act ("Rule 10b5-1 Plan"), adopted or terminated by the Company's Section 16 officers or directors during the three months ended March 28, 2026.

None of the Company's directors or Section 16 officers adopted or terminated a "non-Rule 10b5-1 trading arrangement" as defined in Item 408 of Regulation S-K during the three months ended March 28, 2026.

### ITEM 6. EXHIBITS
(a) Exhibits:

---

| | |
|:---|:---|
| 10.1 | [Agreement, dated as of May 2, 2026, by and between the Company and Beretta Holding S.A](https://www.sec.gov/Archives/edgar/data/95029/000207709626000113/ea028885501ex10-1.htm). (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 4, 2026). |
| 31.1 | [Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*](ex31-1.htm) |
| 31.2 | [Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002\*](ex31-2.htm) |
| 32.1 | [Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*\*](ex32-1.htm) |
| 32.2 | [Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002\*\*](ex32-2.htm) |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | XBRL Taxonomy Extension Schema Document\* |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document\* |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document\* |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document\* |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document\* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
| \*Filed herewith | \*Filed herewith |
| \*\*Furnished herewith | \*\*Furnished herewith |

---

STURM, RUGER & COMPANY, INC.

FORM 10-Q FOR THE THREE MONTHS ENDED MARCH 28, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | STURM, RUGER & COMPANY, INC. |
| Date: May 6, 2026 | S/ANDREW T. WIELAND |
|  | Andrew T. Wieland<br> Principal Financial Officer,<br> Principal Accounting Officer,<br> Senior Vice President and Chief Financial Officer |

---

## Exhibit 31.1

EXHIBIT 31.1

CERTIFICATION

I, Todd W. Seyfert, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q (the "Report") of Sturm, Ruger & Company,
Inc. (the "Registrant");

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this Report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this Report,
fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for,
the periods presented in this Report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The Registrant's other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented
in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this Report any change in the Registrant's internal control over financial reporting
that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over
financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation
of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board
of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the Registrant's internal control over financial reporting.

Date: May 6, 2026

<u>S/TODD W. SEYFERT</u> 

Todd W. Seyfert

Chief Executive Officer

## Exhibit 31.2

EXHIBIT 31.2

CERTIFICATION

I, Andrew T. Wieland, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this Quarterly Report on Form 10-Q (the "Report") of Sturm, Ruger & Company,
Inc. (the "Registrant");

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this Report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this Report,
fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for,
the periods presented in this Report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The Registrant's other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented
in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this Report any change in the Registrant's internal control over financial reporting
that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over
financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation
of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board
of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report
financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the Registrant's internal control over financial reporting.

Date: May 6, 2026

<u>S/ANDREW T. WIELAND</u> 

Andrew T. Wieland

Senior Vice President and

Chief Financial Officer

## Exhibit 32.1

EXHIBIT 32.1

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Sturm, Ruger & Company, Inc. (the "Company") for the period ended March 28, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Todd W. Seyfert, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respect, the financial condition
and results of operations of the Company.

Date: May 6, 2026 <u>S/TODD W. SEYFERT</u> <br> Todd W. Seyfert <br> Chief Executive Officer

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

EXHIBIT 32.2

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Sturm, Ruger & Company, Inc. (the "Company") for the period ended March 28, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Andrew T. Wieland, Senior Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respect, the financial condition
and results of operations of the Company.

---

| | |
|:---|:---|
| Date: May 6, 2026 | <u>S/ANDREW T. WIELAND</u> |
|  | Andrew T. Wieland |
|  | Senior Vice President and |
|  | Chief Financial Officer |

---

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.